Flexible Approaches for Biotech Companies in Clinical Trials
Listen now
Description
With fewer people covering more roles with less specialization and novel therapeutics with unique testing requirements, the needs of small biotech companies in clinical trials are different from larger sponsors. In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Mona Henderson, Director of Laboratory Network Solutions (both at Q2 Solutions) discuss how our dedicated biotech teams focus specifically on the unique needs of those customers. Alex and Mona cover: Operational strategy, from supply chain to data management The role of LNS in contracting and managing specialty, third-party labs Collaboration with our parent company, IQVIA and Adapting to evolving customer strategies  You can learn more at https://q2labsolutions.com/biotech.  
More Episodes
In this episode, Dr. Monika Lamba, a pathologist from Q² Solutions, discusses the transformative role of digital pathology in clinical trials. Despite its origins aiming to streamline trials, it's not yet the default. Dr. Lamba explores its evolution from telepathology and its integration into...
Published 11/17/23
In this episode Dr. Monika Lamba Saini and Bruno Larvol of “LARVOL & Friends” discuss the role of artificial intelligence (AI) in pathology and its potential impact on healthcare. They delve into the slower adoption of AI in pathology compared to other medical specialties and examine the...
Published 06/30/23